Related Experiment Video
Updated: Dec 20, 2025
07:44
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
6.4K
Advances in stent therapy for malignant biliary obstruction.
Xin He1, Ying Zhu1, Yining Wang1,2,3
1Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.
Abdominal Radiology (New York)
|May 27, 2020
Summary
Biliary stent therapy offers a promising approach for malignant biliary obstruction (MBO). This review examines current stent options and future innovations like 3D-printed stents for improved MBO palliation.
Area of Science:
- Gastroenterology and Hepatology
- Oncology
- Biomedical Engineering
Background:
- Malignant biliary obstruction (MBO) is a challenging condition, often diagnosed in inoperable patients.
- Current treatments like radiotherapy and chemotherapy show limited efficacy for MBO.
- Biliary stent therapy is a key strategy for palliation, but optimal stent selection remains difficult.
Purpose of the Study:
- To review the safety and efficacy of current biliary stents for MBO palliation.
- To explore combination therapies including brachytherapy, photodynamic therapy, and advanced chemotherapeutics.
- To discuss future prospects of novel stent designs, such as 3D-printed and nanoparticle-loaded stents.
Main Methods:
- Systematic review of safety and efficacy data for various biliary stents.
- Analysis of combination therapies involving stents with radiation, light, and chemotherapy.
- Evaluation of emerging stent technologies for MBO management.
Main Results:
- Biliary stents are effective in palliating MBO and improving patient survival.
- Combination therapies may enhance treatment outcomes but require careful consideration.
- Novel stent designs, including 3D-printed and nanoparticle-loaded options, show significant potential.
Conclusions:
- Optimal biliary stent selection is crucial for effective MBO palliation.
- Future research should focus on personalized stent strategies and managing stent-related complications.
- Innovations in stent technology promise improved outcomes for pancreatobiliary malignancies.
